Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-D for Thrombocytopenia in HCV Patients
NCT00239733Phase 4Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2005
- Primary completion
- Feb 2010
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of rho(d) immune globulin in Thrombocytopenia, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2005; status: terminated.
02
Drugs
rho(d) immune globulin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00239733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239733.